Embecta Corp. focuses on diabetes products and recently received FDA approval for a new patch pump. Read why I'm neutral on ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

Researchers have discovered that remodeling of extracellular matrix (ECM) in the hypothalamus, specifically around AgRP ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

Type 2 diabetes is characterized by the body's inability to use insulin effectively. Insulin is a hormone that helps regulate metabolism properly. The condition is the most common type of ...

Investigating ECM changes in the hypothalamus reveals mechanisms behind insulin resistance, offering insights into obesity ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...

For the first time, scientists have found that proteins from bacteria can trigger the immune system to attack ...

Ozempic is not approved for use in weight loss, however, many people have been taking the drug for this purpose. Semaglutide was approved for weight loss purposes under another name—Wegovy—which has a ...